MiR-491-3p is down-regulated in postmenopausal osteoporosis and affects growth, differentiation and apoptosis of hFOB1.19 cells through targeting CTSS.

CONCLUSIONS: Our outcomes illustrated that miR-491-3p could ameliorate hFOB1.19 cells biological characteristics through reducing CTSS, suggesting that miR-491-3p/CTSS might be potential biomarkers for the diagnosis and treatment of PMO. PMID: 32176315 [PubMed - as supplied by publisher]
Source: Folia Histochemica et Cytobiologica - Category: Cytology Tags: Folia Histochem Cytobiol Source Type: research